Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EB06 in moderate to severe non-segmental vitiligo
NCT07889492Phase 2Recruiting
- Sponsor
- Edesa Biotech, Inc.
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of NI-0801 in Vitiligo, sponsored by Edesa Biotech, Inc.. Started Sep 2026; status: recruiting.
02
Drugs
NI-0801
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07889492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07889492.